Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.

被引：0
|
作者：
Canzanello, VJ [1 ]
Schwartz, LL [1 ]
Taler, SJ [1 ]
Textor, SC [1 ]
Atwood, G [1 ]
Porayko, MK [1 ]
Wiesner, RH [1 ]
Krom, RAF [1 ]
机构：
[1] MAYO CLIN,ROCHESTER,MN
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1443 / 1443
页数：1
相关论文
共 50 条
  • [1] CyA to tacrolimus (FK506) conversion in liver transplant recipients
    Cuomo, O
    Iovine, L
    Carfora, T
    De Luca, M
    Di Palma, M
    Anello, R
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C39 - C39
  • [2] Effect of conversion from cyclosporine to tacrolimus on cardiovascular risk profile in renal transplant recipients
    Do, Wonseok
    Kwon, Eugene
    Kim, Geun-Hee
    Lee, Kyung Hee
    Kim, Kyu Yeun
    Kim, Minjung
    Yang, Youngae
    Yim, Taehoon
    Hwang, Inryang
    Lee, Sukyung
    Jung, Hee-Yeon
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    [J]. TRANSPLANTATION, 2016, 100 (07) : S691 - S691
  • [3] Population pharmacokinetic study of tacrolimus (FK506) in adult liver transplant recipients.
    Zahir, H
    Nelson, A
    Gleeson, M
    McCaughan, G
    McLachlan, AJ
    Akhlaghi, F
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 365 - 365
  • [4] Screening for hypomagnesemia in cyclosporine or FK 506 treated renal transplant recipients.
    Gupta, BK
    Glicklich, D
    [J]. TRANSPLANTATION, 1999, 67 (07) : S152 - S152
  • [5] Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy
    Ben-Ari, Z
    Mor, E
    Shaharabani, E
    Bar-Nathan, N
    Shapira, Z
    Tur-Kaspa, R
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (04) : 709 - 710
  • [6] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    Wallemacq, PE
    Furlan, V
    Möller, A
    Schäfer, A
    Stadler, P
    Firdaous, I
    Taburet, AM
    Reding, R
    De Clety, SC
    De Goyet, JD
    Sokal, E
    Lykavieris, L
    Van Leeuw, V
    Bernard, O
    Otte, JB
    Undre, NA
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (03) : 367 - 370
  • [7] BEST SINGLE TIME POINT MEASUREMENT CORRELATIONS WITH AUC FOR CYCLOSPORINE ( CSA) AND TACROLIMUS ( FK) IN HIV- INFECTED LIVER AND KIDNEY TRANSPLANT RECIPIENTS.
    Tan-Tam, C. C.
    Frassetto, L. A.
    Barin, B.
    Browne, M.
    Wolfe, A. R.
    Stock, P. G.
    Roland, M.
    Benet, L. Z.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S22 - S23
  • [8] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    P. E. Wallemacq
    V. Furlan
    A. Möller
    A. Schäfer
    P. Stadler
    I. Firdaous
    A -M. Taburet
    R. Reding
    S. Clement De Clety
    J. De Ville De Goyet
    E. Sokal
    L. Lykavieris
    V. Van Leeuw
    O. Bernard
    J. B. Otte
    N. A. Undre
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 367 - 370
  • [9] Cardiovascular risk profile before and after tacrolimus conversion in kidney transplant recipients.
    Luan, Fu L.
    Miles, Clifford D.
    Blosser, Christopher
    Cibrik, Diane M.
    Norman, Silas
    Chopra, Pavan
    Ojo, Akinlolu A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 534 - 534
  • [10] Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: A single center experience
    Ichikura, H
    Tanabe, K
    Tokumoto, T
    Shimuzu, T
    Ishikawa, N
    Harano, M
    Inui, M
    Manu, M
    Ito, S
    Shimmura, H
    Okuda, H
    Yagisawa, T
    Fuchinoue, S
    Toma, H
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1733 - 1735
12345